A Randomized, Placebo Controlled, Double-masked, Multicenter Trial of Microplasmin Intravitreal Injection for Non-surgical Treatment of Focal Vitreomacular Adhesion.

Status: Completed

Phase of Trial: Phase III

Latest Information Update: 19 Jul 2021

Price : $35 ^*

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

01 Dec 2017 Results of post hoc analysis of two trial (NCT00781859 and NCT00798317) assessing effect of an intravitreal ocriplasmin injection on visual function, measured using visual acuity (VA) and vision-related quality of life, were published in the Acta Ophthalmologica.
01 Jul 2015 Results: pooled analysis, phase III studies published in the American Journal of Ophthalmology.
04 Jun 2014 Pooled analysis ( MIVI -TRUST) results presented at the 19th Annual International Meeting of the International Society for Pharmacoeconomics and Outcomes.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com